Photodynamic therapy with methyl aminolevulinate for prevention of new skin lesions in transplant recipients: A randomized study

Transplantation

Volumn 86, Issue 3, 2008, Pages 423-429

  Wennberg, Ann Marie ^a   Stenquist, Bo ^a   Stockfleth, Eggert ^b   Keohane, Stephen ^c   Lear, John T ^d   Jemec, Gregor ^e   Mork, Cato ^f   Christensen, Eidi ^g   Kapp, Alexander ^h   Solvsten, Henrik ^e,l   Talme, Toomas ⁱ   Berne, Berit ^j   Forschner, Tobias ^b,k  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c ST MARY S HOSPITAL   (United Kingdom)

^d MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^e Roskilde Amtsygehus ^*  (Denmark)

^f OSLO UNIVERSITY HOSPITAL   (Norway)

^g TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^h HANNOVER MEDICAL SCHOOL   (Germany)

ⁱ KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^j UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^k Meoclinic   (Germany)

^l Aarhus Universitetshospital   (Denmark)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID METHYL ESTER; IMMUNOSUPPRESSIVE AGENT; AMINOLEVULINIC ACID; DRUG DERIVATIVE; METHYL 5-AMINOLEVULINATE; PHOTOSENSITIZING AGENT;

ACTINIC KERATOSIS; ADULT; AGED; ARTICLE; BASAL CELL CARCINOMA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRYOTHERAPY; DEBRIDEMENT; DRUG EFFICACY; FACE; FEMALE; GRAFT RECIPIENT; HUMAN; HUMAN TISSUE; HYPOPIGMENTATION; LIMB; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NECK; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RED LIGHT; SCALP; SQUAMOUS CELL CARCINOMA; TREATMENT RESPONSE; TRUNK; VERRUCA VULGARIS; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; EUROPE; KERATOSIS; MIDDLE AGED; ORGAN TRANSPLANTATION; PATHOLOGY; PHOTOCHEMOTHERAPY; TOPICAL DRUG ADMINISTRATION; TREATMENT OUTCOME;

ADMINISTRATION, TOPICAL; ADULT; AGED; AMINOLEVULINIC ACID; CRYOTHERAPY; EUROPE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KERATOSIS; MALE; MIDDLE AGED; ORGAN TRANSPLANTATION; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; TREATMENT OUTCOME;

EID: 52049107209     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e318180731e     Document Type: Article

References (39)

1. Jensen P, Hansen S, Moller B, et al. Skin cancer in kidney and heart transplant recipients and different long-term immunotherapy regimens. J Am Acad Dermatol 1999; 40: 177.
2. Leigh IM, Glover MT. Skin cancer and warts in immunosuppressed renal transplant recipients. Recent Results Cancer Res 1995; 139: 69.
3. Dreno B, Mansat E, Legoux B, et al. Skin cancer in transplant patients. Nephrol Dial Transplant 1998; 13: 1374.
4. Marks R, Rennie G, Selwood TS. Malignant transformation of solar keratosis to squamous cell carcinoma. Lancet 1988; 1: 795.
5. Bouwes Bavinck JN, Vermeer BJ, van der Woude FJ, et al. Relation between skin cancer and HLA antigens in renal-transplant recipients. N Engl J Med 1991; 325: 843.
6. Adami J, Gabel H, Lindelof B, et al. Cancer risk following organ transplantation: A nationwide cohort study in Sweden. Br J Cancer 2003; 89: 1221.
7. Bavinck JN, De Boer A, Vermeer BJ, et al. Sunlight, keratotic skin lesions and skin cancer in renal transplant recipients. Br J Dermatol 1993; 129: 242.
8. Bouwes Bavinck JN. Epidemiological aspects of immunosuppression: Role of exposure to sunlight and human papillomavirus on the development of skin cancer. Hum Exp Toxicol 1995; 14: 98.
9. Barr BB, Benton EC, McLaren K, et al. Human papilloma virus infection and skin cancer in renal allograft recipients. Lancet 1989; 1: 124.
10. Moloney FJ, Comber H, O'Lorcain P, et al. A population-based study of skin cancer incidence and prevalence in renal transplant recipients. Br J Dermatol 2006; 154: 498.
11. Hartevelt MM, Bavinck JN, Kootle AM, et al. Incidence of skin cancer after renal transplantation in the Netherlands. Transplantation 1990; 49: 506.
12. Bouwes Bavinck JN, Hardie DR, Green A, et al. The risk of skin cancer in renal transplant recipients in Queensland, Australia. Transplantation 1996; 61: 715.
13. Hardie IR, Strong RW, Hartley LC, et al. Skin cancer in Caucasian renal allografts recipients living in a subtropical climate. Surgery 1980; 87: 117.
14. Ramsay H, Fryer AA, Hawley CM, et al. Non-melanoma skin cancer risk in the Queensland renal transplant population. Br J Dermatol 2002; 147: 950.
15. Lindelof B, Jarnvik J, Ternesten-Bratel A, et al. Mortality and clinicopathological features of cutaneous squamous cell carcinoma in organ transplant recipients: A study of the Swedish cohort. Acta Derm Venereol 2006; 86: 219.
16. Boyle J, MacKie RM, Briggs JD, et al. Cancer, warts and sunshine in renal transplant patients. Lancet 1984; 1: 702.
17. Berg D, Otley C. Skin cancer in organ transplant recipients: Epidemiology, pathogenesis, and management. J Am Acad Dermatol 2002; 47:1.
18. Braathen LR, Szeimies R-M, Basset-Seguin N, et al. Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: An international consensus. International Society for Photodynamic Therapy in Dermatology, 2005. J Am Acad Dermatol 2007; 56: 125.
19. Siddiqui MA, Perry CM, Scott LJ. Topical methyl aminolevulinate. Am J Clin Dermatol 2004; 5: 127.
20. Sharfaei S, Juzenas P, Moan J, et al. Weekly topical application of methyl aminolevulinate followed by light exposure delays the appearance of UV-induced skin tumours in mice. Arch Dermatol Res 2002; 294: 237.
21. StenderIM, Bech-ThomsenN, PoulsenT, etal. Photodynamic therapy with topical γ-aminolevulinic acid delays UV photocarcinogenesis in hairless mice. Photochem Photobiol 1997; 66: 493.
22. Dragieva G, Prinz BM, Hafner J, et al. A randomized controlled clinical trial of topical photodynamic therapy with methyl aminolaevulinate in the treatment of actinic keratoses in transplant recipients. Br J Dermatol 2004; 151: 196.
23. Wulf HC, Pavel S, Stender I, et al. Topical photodynamic therapy for prevention of new skin lesions in renal transplant recipients. Acta Derm Venereol 2006; 86: 25.
24. Perrett CM, McGregor JM, Warwick J, et al. Treatment of post-transplant premalignant skin disease: A randomized intrapatient comparative study of 5-fluorouracil cream and topical photodynamic therapy. Br J Dermatol 2007; 156: 320.
25. Olsen EA, Abernethy L, Kulp-Shorten C, et al. A double-blind vehicle controlled study evaluating masoprocol cream in the treatment of actinic keratoses on the head and neck. J Am Acad Dermatol 1991; 24:738.
26. de Graaf YG, Kennedy C, Wolterbeek R. Photodynamic therapy does not prevent cutaneous squamous-cell carcinoma in organ-transplant recipients: Results of a randomized-controlled trial. J Invest Dermatol 2006; 126: 569.
27. Piaserico S, Belloni Fortina A, Rigotti P, et al. Topical photodynamic therapy of actinic keratosis in renal transplant recipients. Transplant Proc 2007; 3: 1847.
28. Freeman M, Vinciullo C, Francis D, et al. A comparison of photodynamic therapy using topical methyl aminolevulinate (Metvix®) with single cycle of cryotherapy in patients with actinic keratosis: A prospective, randomized study. J Dermatol Treat 2003; 14: 99.
29. Pariser DM, Lowe NJ, Stewart DM, et al. Photodynamic therapy with topical methyl aminolevulinate for actinic keratosis: Results of a prospective randomized multicenter trial. J Am Acad Dermatol 2003; 48: 227.
30. Tarstedt M, Rosdahl I, Berne B, et al. A randomized multicenter study to compare two treatment regimens of topical methyl aminolevulinate (Metvix)-PDT in actinic keratosis in face and scalp. Acta Derm Venereol 2005; 85: 424.
31. Morton C, Campbell S, Gupta G, et al. Intraindividual, right-left comparison of topical methyl aminolaevulinate-photodynamic therapy and cryotherapy in subjects with actinic keratoses: A multicenter, randomized controlled study. Br J Dermatol 2006; 155: 1029.
32. Lehmann P. Methyl aminolaevulinate-photodynamic therapy: A review of clinical trials in the treatment of actinic keratoses and nonmelanoma skin cancer. Br J Dermatol 2007; 156: 793.
33. Wennberg AM. Pain, pain relief, and other practical issues in photodynamic therapy. Australas J Dermatol 2005; 45(Suppl 2): S3.
34. Borelli C, Herzinger T, Merk K, et al. Effect of subcutaneous infiltration anesthesia on pain in photodynamic therapy: A controlled open pilot trial. Dermatol Surg 2007; 33: 314.
35. Paoli J, Halldin C, Ericson MB, et al. Nerve blocks provide effective pain relief during topical photodynamic therapy for extensive facial actinic keratoses. Clin Exp Dermatol (in press).
36. Grapengiesser S, Gudmundsson F, Larkö O, et al. Pain caused by photodynamic therapy of the skin. Clin Exp Dermatol 2002; 27: 493.
37. Lindelof B, Sigurgeirsson B, Gabel H, et al. Incidence of skin cancer in 5356 patients following organ transplantation. Br J Dermatol 2000; 143: 513.
38. Otley CC. Organization of a speciality clinic to optimize the care of organ transplant recipients at risk for skin cancer Dermatol Surg 2000; 26: 709.
39. Christenson LJ, Geusau A, Ferrandizet C, et al. Speciality clinics for the dermatologic care of solid organ transplant recipients. Dermatol Surg 2004; 30: 598.